The European Commission fined Teva and Cephalon € 60.5 million for their agreement to delay marketing of a cheaper generic version of Cephalon’s drug for sleep disorders, modafinil. The press release dated 26 November 2020 about the decision of the European Commission is available at https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2220